Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0042571 (
vertigo
)
7,148
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
An elevation of the plasma
arginine vasopressin
(
AVP
) level has frequently been observed in Meniere's disease patients. However, little is known regarding the mechanism behind this elevation. The plasma
AVP
levels in acute phase were determined in 21 Meniere's disease patients and 16 patients with other types of
vertigo
. The plasma
AVP
levels of Meniere's disease patients in the acute phase were significantly higher than in those of other
vertigo
patients (p < 0.01). In Meniere's disease patients with abnormally high levels of
AVP
(more than 3.5 pg/ml) in the acute phase, 36% of patients were resistant to conservative treatments for frequent
vertigo
attacks for the follow-up period of at least 2years. A significant correlation was observed between the plasma
AVP
in the acute phase and the highest hearing threshold level at a frequency of 1kHz for the follow-up period of at least 1 year (r=0.45, p < 0.05). These results suggest that the elevation in plasma
AVP
level in the acute phase is associated with the prognosis of Meniere's disease.
...
PMID:The association of the plasma vasopressin level during attacks with a prognosis of Meniere's disease. 2107 7